Coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) virus, is a global pandemic impacting 254 million people in …

Background There is growing evidence that patients with COVID-19 are at increased risk of
new-onset diabetes. The limited preliminary studies do not provide strong evidence. To …

Simple Summary Accumulating evidence suggests that the severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) may have the potential to induce pancreatic β-cell …

Children seem to be affected by the new SARS-CoV-2 virus less severely than adults, with
better prognosis and low mortality. Serious complications of COVID-19 infection in children …

The novel severe acute respiratory distress syndrome-coronavirus 2 (SARS-CoV-2) has
caused one of the most substantial pandemics that has affected humanity in the last century …

A significantly higher rate of new-onset diabetes in many coronavirus disease 2019 (COVID-
19) patients is a frequently observed phenomenon. The resultant hyperglycemia is known to …

As the population of patients recovering from COVID-19 grows, post COVID-19 challenges
are recognizing by ongoing evidences at once. Long COVID is defined as a syndrome with a …

Context The effects of the coronavirus disease 2019 (COVID-19) pandemic on the incident
cases of pediatric type 1 diabetes (T1D) and type 2 diabetes (T2D) are not clear. Objective …

Introduction. New onset of diabetes mellitus was noted as the commonest comorbidity in the
COVID‐19 pandemic, which contributed to a worse prognosis. Existing evidence showed …

The pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-
2) infection is one of the world's most disruptive health crises. The presence of diabetes …